INHIBIN AS A MARKER FOR HYDATIDIFORM MOLE - A COMPARATIVE-STUDY WITH THE DETERMINATIONS OF INTACT HUMAN CHORIONIC-GONADOTROPIN AND ITS FREEBETA-SUBUNIT
Y. Badonnel et al., INHIBIN AS A MARKER FOR HYDATIDIFORM MOLE - A COMPARATIVE-STUDY WITH THE DETERMINATIONS OF INTACT HUMAN CHORIONIC-GONADOTROPIN AND ITS FREEBETA-SUBUNIT, Clinical endocrinology, 41(2), 1994, pp. 155-162
OBJECTIVE The purpose of the study was to evaluate plasma inhibin as a
marker of hydatidiform mole and to compare the results with intact hu
man chorionic gonadotrophin (hCG) and its free beta-subunit. DESIGN Se
rial determinations of the plasma concentrations of inhibin, intact hu
man chorionic gonadotrophin and its free beta-subunit in cases of hyda
tidiform mole over an average period of 140 days. PATIENTS Five cases
of hydatidiform mole, including patients with spontaneous remission af
ter evacuation or persistent trophoblastic disease. MEASUREMENTS Immun
oreactive inhibin, hCG and free hCG beta-subunit were measured using s
tandard enzyme immunoassays. RESULTS Inhibin and free hCG beta-subunit
levels were greater than in normal pregnant women at the same gestati
onal age. Only intact hCG could detect the persistence of trophoblasti
c tissue. CONCLUSIONS Our data suggest that inhibin, intact human chor
ionic gonadotrophin and free beta-subunit might be useful as diagnosti
c markers of molar pregnancies. However, the original method of intact
hCG determination is still superior for follow-up.